0001235802-22-000024.txt : 20220202
0001235802-22-000024.hdr.sgml : 20220202
20220202164527
ACCESSION NUMBER: 0001235802-22-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cundari Dominic R
CENTRAL INDEX KEY: 0001907057
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 22584327
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY, SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-02-01
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001907057
Cundari Dominic R
TWO CARLSON PARKWAY, SUITE 260
MINNEAPOLIS
MN
55447
0
1
0
0
Chief Commercial Officer
Voting Common Shares, no par value per share
2800
D
Stock Option (right to buy)
2.9
2022-02-01
4
A
0
125000
0
A
2032-02-01
Common Shares
125000
125000
D
Stock Option (right to buy)
2.9
2022-02-01
4
A
0
40000
0
A
2032-02-01
Common Shares
40000
40000
D
This option vests with respect to 31,250 common shares on February 1, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.
This option vests with respect to 10,000 common shares on May 1, 2022 and with respect to the remaining 75% of the common shares in three nearly equal installments on each of August 1, 2022, November 1, 2022 and February 1, 2023.
/s/ Amy Culbert, attorney-in-fact
2022-02-02